Dr. Winter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Ave
Cleveland, OH 44195- Is this information wrong?
Education & Training
Cleveland Clinic FoundationResidency, Internal Medicine, 2013 - 2016
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2013
Certifications & Licensure
OH State Medical License 2013 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma Start of enrollment: 2019 Mar 12
Publications & Presentations
PubMed
- Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia.Hill, B., Ma, S., Zent, C., Baran, A., Wallace, D., Advani, A., Winter, A., Winter, J., Gordan, L., Karmali, R., Liesveld, J., Mulford, D., Rowland, C., Bui, A., Sport...> ;Blood Advances. 2024 Jan 23
- The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma.Gabriel F P Aleixo, Wei Wei, Po-Hao Chen, Namita S Gandhi, Faiz Anwer, Robert Dean, Betty K Hamilton, Brian T Hill, Deepa Jagadeesh, Jack Khouri, Brad Pohlman, Ronald ...> ;Bone Marrow Transplantation. 2023 Dec 1
- 4 citationsDiminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia.Chaitra Ujjani, Ted A Gooley, Stephen E Spurgeon, Deborah M Stephens, Catherine Lai, Catherine M Broome, Susan O'Brien, Haiying Zhu, Kerry J Laing, Allison M Winter, G...> ;Blood Advances. 2023 Sep 12
- Join now to see all
Abstracts/Posters
- Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat AnalysisAllison M. Winter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular TherapiesAllison M. Winter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
